Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01946217 · ClinicalTrials.gov registry record
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials
A clinical trial of HIV Infection and Malignant Neoplasm, sponsored by AIDS Malignancy Consortium.
- Completed
- Registry status
- 82
- Enrollment target
- 14
- Study locations
NCT01946217: Completed study of HIV Infection and Malignant Neoplasm, sponsored by AIDS Malignancy Consortium.
NCT01946217 is a study of HIV Infection and Malignant Neoplasm that has completed, run by AIDS Malignancy Consortium. The registered enrollment target is 82 participants, below the 242-participant average among 73 other HIV Infection trials with a reported enrollment target (66% lower). The trial reports 14 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01946217, a study of HIV Infection and Malignant Neoplasm, has completed, sponsored by AIDS Malignancy Consortium.
- COMPLETED
- Registry status
- 82 participants
- Enrollment target
- 14
- Study locations
Study Summary
This pilot research trial studies factors affecting patient participation in Acquired Immune Deficiency Syndrome (AIDS) Malignancy Clinical Trials Consortium clinical trials. Determining how patients makes decisions about participating in a clinical trial may help doctors plan clinical trials in which more patients are willing to participate and are satisfied with their decision to participate.
Primary Outcome
The proportion of individuals who are screened and agree to enroll in a clinical trial will be estimated with the binomial proportion and its 95% confidence interval.
Conditions Studied
Interventions
- OTHER questionnaire administration
Study Locations (14)
New York
- Laser Surgery Care - New York
- Memorial Sloan-Kettering Cancer Center - New York
- Albert Einstein Cancer Center at Albert Einstein College of Medicine - The Bronx
- Montefiore-Einstein Cancer Center - The Bronx
- Montefiore Medical Center - The Bronx
Louisiana
- Interim LSU Public Hospital - New Orleans
- HIV Out-patient Clinic - New Orleans
- NO AIDS Clinic - New Orleans
Washington
- Virginia Mason Medical Center - Seattle
- Harborview Madison Clinic - Seattle
- Seattle Cancer Care Alliance - Seattle
California
- UCLA Clinical AIDS Research and Education (CARE) Center - Los Angeles
Illinois
- Stroger Hospital of Cook County - Chicago
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2013-09 |
| Est. Completion | 2015-09 |
What the finished NCT01946217 record still lists
NCT01946217 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 82 participants, a relatively small participant target, below the 242-participant average among 73 other HIV Infection trials with a reported enrollment target (66% lower).
The record links to 3 conditions, with HIV Infection appearing as the primary indexed condition, and to 1 intervention - of which questionnaire administration is the first listed.
NCT01946217 lists 14 locations in 6 states (New York, Louisiana, Washington).
Frequently Asked Questions
What is clinical trial NCT01946217 about?
NCT01946217 is a clinical study titled "Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials". This pilot research trial studies factors affecting patient participation in Acquired Immune Deficiency Syndrome (AIDS) Malignancy Clinical Trials Consortium clinical trials. Determining how patients makes decisions about participating in a clinical trial may help doctors plan clinical trials in whi...
What is the current status of trial NCT01946217?
This trial is currently completed. The enrollment target is 82 participants. The study started on 2013-09. Estimated completion is 2015-09.
What conditions does trial NCT01946217 study?
This clinical trial studies the following conditions: HIV Infection, Malignant Neoplasm, Precancerous Condition.
What interventions are being tested in trial NCT01946217?
The interventions under investigation include: questionnaire administration (OTHER).
Who is sponsoring clinical trial NCT01946217?
This trial is sponsored by AIDS Malignancy Consortium, which has 45 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01946217 being conducted?
This trial has 14 study locations across California, Illinois, Louisiana, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01946217's enrollment target sits among peer trials
82 30th of 73 higher than 44 of 73 other HIV Infection trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
RECRUITING · Phase 2
-
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
RECRUITING · Phase 1
-
MAPS PrEP Van Study
RECRUITING · Phase 4
-
HIV+ Deceased Donor Heart Transplant Study for HIV+ Recipients
RECRUITING · NA
-
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
RECRUITING · NA
-
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03319901 · 82 participants · Phase 1
Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL
- NCT03493425 · 82 participants · Phase 2
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery
- NCT04105270 · 82 participants · Phase 2
RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
- NCT04428658 · 82 participants · NA
Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia